AbbVie

YTD

ALL

Trade AbbVie 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.

CEO

Robert A. Michael

CEORobert A. Michael

Employees

55,000

Employees55,000

Headquarters

North Chicago, Illinois

HeadquartersNorth Chicago, Illinois

Founded

2011

Founded2011

Employees

55,000

Employees55,000

ABBV Key Statistics

Market cap

327.76B

Market cap327.76B

Price-Earnings ratio

78.07

Price-Earnings ratio78.07

Dividend yield

3.48%

Dividend yield3.48%

Average volume

6.55M

Average volume6.55M

High today

$186.75

High today$186.75

Low today

$182.69

Low today$182.69

Open price

$183.29

Open price$183.29

Volume

4.73M

Volume4.73M

52 Week high

$218.66

52 Week high$218.66

52 Week low

$153.58

52 Week low$153.58

ABBV News

Simply Wall St 1d

AbbVie Showcases Promising Phase 1 ADC Results For Advanced Cancers

recently unveiled promising data on its investigational therapies, including the novel c-Met-targeting ADC, Temab-A, and the SEZ6-directed ADC, ABBV-706, indica...

Analyst ratings

60%

of 30 ratings

Buy

60%

Hold

36.7%

Sell

3.3%

People also own

Based on the portfolios of people who own ABBV. This list is generated using Robinhood data, and it’s not a recommendation.